HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniela M Zisterer Selected Research

Transferases

3/2020β-Lactams with antiproliferative and antiapoptotic activity in breast and chemoresistant colon cancer cells.
4/2017β-Lactam analogues of combretastatin A-4 prevent metabolic inactivation by glucuronidation in chemoresistant HT-29 colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniela M Zisterer Research Topics

Disease

30Neoplasms (Cancer)
02/2022 - 06/2005
28Breast Neoplasms (Breast Cancer)
10/2021 - 07/2005
6Osteoporosis
08/2017 - 07/2005
6Carcinoma (Carcinomatosis)
09/2013 - 11/2005
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2010 - 05/2002
4Neuroblastoma
11/2017 - 01/2013
4Adenocarcinoma
06/2013 - 12/2010
4Polyploidy
05/2011 - 04/2007
3Colonic Neoplasms (Colon Cancer)
03/2020 - 06/2013
3Necrosis
01/2018 - 07/2016
3Leukemia
11/2010 - 09/2004
2Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2018 - 05/2011
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2016 - 01/2013
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2016 - 09/2004
2Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 08/2013
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2015 - 11/2010
2Hematologic Neoplasms (Hematological Malignancy)
08/2013 - 04/2009
1Multiple Myeloma
02/2022
1Squamous Cell Carcinoma of Head and Neck
01/2021
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2018
1Inflammation (Inflammations)
01/2018
1Liver Neoplasms (Liver Cancer)
04/2017
1Melanoma (Melanoma, Malignant)
07/2016
1Lung Neoplasms (Lung Cancer)
01/2016
1Kidney Neoplasms (Kidney Cancer)
09/2015
1Neoplasm Metastasis (Metastasis)
12/2014
1Anaplastic Thyroid Carcinoma
09/2012
1Fibrosarcoma
09/2012

Drug/Important Bio-Agent (IBA)

15TubulinIBA
10/2021 - 02/2008
10Pharmaceutical PreparationsIBA
10/2021 - 03/2006
10LactamsIBA
03/2020 - 11/2010
9Estrogen ReceptorsIBA
02/2021 - 07/2005
8PBOX-6IBA
10/2016 - 09/2004
6Proteins (Proteins, Gene)FDA Link
01/2018 - 02/2008
6LigandsIBA
08/2017 - 11/2007
5fosbretabulin (combretastatin A4)IBA
10/2021 - 04/2011
4Hormones (Hormone)IBA
08/2017 - 11/2005
44- acetoxy- 5- (1- (naphthyl))naphtho(2,3- b)pyrrolo(2,1- d)(1,4)oxazepineIBA
08/2013 - 04/2008
4CA 432IBA
02/2013 - 11/2010
3Guanidine (Guanidine Nitrate)FDA Link
02/2022 - 04/2018
3combretastatinIBA
04/2019 - 05/2011
3Phosphotransferases (Kinase)IBA
06/2014 - 09/2004
3DNA (Deoxyribonucleic Acid)IBA
12/2010 - 02/2008
3Estrogen Receptor Modulators (Antiestrogen)IBA
10/2007 - 07/2005
3Raloxifene Hydrochloride (Evista)FDA Link
03/2007 - 07/2005
3TamoxifenFDA LinkGeneric
03/2007 - 07/2005
2Inhibitor of Apoptosis ProteinsIBA
01/2022 - 07/2019
2Biological ProductsIBA
02/2021 - 09/2015
2UridineIBA
03/2020 - 04/2017
2EnzymesIBA
03/2020 - 04/2017
2TransferasesIBA
03/2020 - 04/2017
2resazurinIBA
01/2018 - 01/2013
2Antineoplastic Agents (Antineoplastics)IBA
08/2017 - 06/2005
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
08/2017 - 01/2016
2Carboplatin (JM8)FDA LinkGeneric
10/2016 - 02/2014
2EstersIBA
10/2016 - 04/2013
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2016 - 08/2013
2Selective Estrogen Receptor Modulators (SERM)IBA
01/2016 - 03/2007
2Small Interfering RNA (siRNA)IBA
02/2014 - 05/2011
22-azetidinoneIBA
06/2013 - 09/2012
2Phosphates (Orthophosphate)IBA
04/2013 - 09/2012
2Antimitotic AgentsIBA
12/2010 - 11/2010
2beta-LactamsIBA
11/2010 - 10/2008
2Caspase 3 (Caspase-3)IBA
11/2010 - 01/2010
2Estrogen Receptor AntagonistsIBA
03/2006 - 07/2005
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
02/2022
1SurvivinIBA
01/2022
1Aromatase (CYP19)IBA
02/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1phenylguanidineIBA
12/2020
1CaspasesIBA
01/2020
1Tubulin ModulatorsIBA
04/2019
1CationsIBA
04/2018
1AmidesIBA
04/2018
1CytokinesIBA
01/2018
1AcidsIBA
01/2018
1Cyclin D1IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1BiguanidesIBA
11/2017
1Phenformin (Fenformin)IBA
11/2017
1Estrogens (Estrogen)FDA Link
08/2017
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
10/2016
1AMP-Activated Protein KinasesIBA
10/2016
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
10/2016
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
10/2016
1Cyclic PeptidesIBA
07/2016
1Cytotoxins (Cytolysins)IBA
01/2016
1indoleIBA
01/2016
1Fluorouracil (Carac)FDA LinkGeneric
01/2016
1Oxi 4503IBA
11/2015
1Cytoskeletal ProteinsIBA
12/2014
1Sorafenib (BAY 43-9006)FDA Link
06/2014
14- (3- hydroxy- 4- methoxyphenyl)- 3- (4- hydroxyphenyl)- 1- (3,4,5- trimethoxyphenyl)azetidin- 2- oneIBA
06/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2013
1CA-104IBA
02/2013
1IntegrinsIBA
01/2013
1Molecular Chaperones (Chaperone, Molecular)IBA
10/2011

Therapy/Procedure

4Drug Therapy (Chemotherapy)
01/2022 - 07/2006
2Therapeutics
07/2019 - 06/2013